Core Viewpoint - A class action securities lawsuit has been filed against Walgreens Boots Alliance, Inc. for alleged securities fraud affecting investors between April 2, 2020, and January 16, 2025 [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Walgreens made false statements regarding its commitment to regulatory compliance while continuing to violate federal laws related to prescription medication [2]. - It is alleged that the company's unlawful conduct posed a risk of increased regulatory scrutiny, civil liability, and reputational damage [2]. - The revenues from prescription medication sales were deemed unsustainable due to their reliance on unlawful practices, rendering Walgreens' public statements materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until March 31, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].
Walgreens Boots Alliance, Inc. Class Action: Levi & Korsinsky Reminds Walgreens Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 – WBA